22157.jpg
NIKE Digital Transformation Strategy Analysis Report 2024: Technology Initiatives, Acquisitions, Partnerships & Acquisitions Network Map, ICT Budget and Major Contracts
May 13, 2024 07:30 ET | Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "NIKE - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering.NIKE, Inc. (NIKE) designs, develops,...
DeFiLogoFinal.jpg
DeFi Technologies Subsidiary Valour Inc. Launches Internet Computer (ICP) and Toncoin (TON) ETPs, Landmark Offerings in the Nordics Alongside Chainlink (LINK) ETP
May 13, 2024 07:30 ET | DeFi Technologies Inc.
Valour INC. unveils three groundbreaking Exchange Traded Products: the Valour Internet Computer (ICP), Valour Toncoin (TON), and Valour Chainlink (LINK).
MiNK-logo-loyal-blue-and-light-blue.png
MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
May 13, 2024 07:30 ET | MiNK Therapeutics
Financing of $5.8 Million at a 25% premium will help advance the clinical development of MiNK-215, an armored-FAP-CAR-iNKTGKCC, LLC joins as a new investor with Katie Chudnovsky appointed as a Board...
BB Logo_Tagline_FullColor.png
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at ESC-HF, Including That Acoramidis Treatment Significantly Reduced All-Cause Mortality in a Pre-specified Sensitivity Analysis of the Entire Study Population
May 13, 2024 07:30 ET | BridgeBio Pharma, Inc.
- In a pre-specified Cochran-Mantel-Haenszel sensitivity analysis applied to the entire intention-to-treat (ITT) population of the study (N=632), acoramidis significantly reduced all-cause mortality...
akoustis tm.jpg
Akoustis Reports Third Quarter FY24 Results
May 13, 2024 07:30 ET | Akoustis, Inc.
Q3 Revenue Up 7% Quarter-Over-Quarter Filter-Related Revenue Up 13% Quarter-Over-Quarter, Third Highest in Company History Growth, Cost Savings Initiatives, CHIPS Act ITC Refund Support...
new spectral logo rgb.jpg
Spectral Medical Announces First Quarter Results and Provides Corporate Update
May 13, 2024 07:30 ET | Spectral Medical Inc.
Tigris Trial Enrollment Reaches 106 Patients Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Spectral...
Titan Medical.jpg
Titan Medical Reports Financial Results for the First Quarter 2024
May 13, 2024 07:30 ET | Titan Medical Inc.
TORONTO, Ontario, May 13, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), today reported financial results for the three months ended March 31, 2024. ...
CLM.jpg
CLM Announces Management and Board Changes
May 13, 2024 07:30 ET | Consolidated Lithium Metals Inc.
TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF | FRA: Z36) (“CLM” or the “Company“) is pleased to announce the appointment of Brett Lynch as...
Avalo-Final_Black-01.jpg
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
May 13, 2024 07:30 ET | Avalo Therapeutics
Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027 ...
dLab erhåller en ord
dLab erhåller en order om cirka 800 000 SEK av Gotlands Energi AB
May 13, 2024 07:30 ET | Dlaboratory Sweden AB
Lund, 13 maj 2024 Dlaboratory Sweden AB (publ) meddelar idag att bolaget har erhållit en order om cirka 800 000 SEK från Gotlands Energi AB. Ordern avser dLabs intelligenta platform där Gotlands...